Oncolytics Biotech Inc T.ONC

CDN biopharm company rumored for $US 7-8 Bln BMS acquisition

[Noteable]

Rumors of Bristol Myers Squibb is reportedly courting the Canadian biopharma company Aurinia to strike a buyout deal has surfaced recently. 

"Aurinia recently made history with the first oral drug approved by the FDA for the treatment of lupus nephritis, a serious kidney-related progression of systemic lupus erythematosus. This is the first drug to snag U.S. approval for the Canadian company. "

Experts anticipate the price tag for its acquisition in the ballpark of $ US 7-8 billion.  

https://www.biospace.com/article/buyout-rumors-send-canadian-biopharma-s-stock-soaring-/

[Noteable]

It is important to note that Aurinia's lead product voclosporin was developed by the Alberta company Isotechnika and later licensed in by Aurinia, a spin-out from Vifor Pharma ("Vifor"), a company of the Switzerland-based Galenica Group ("Galenica"). Aurinia eventually bought the company and name as referenced below.  https://www.globenewswire.com/news-release

[Noteable]

https://edmontonglobal.ca/locally-developed-drug-secures-fda-approval/

[fox7mf]

Gee, for a second there I thought maybe that $7b-$8b was rumored to be coming Oncy's way, but alas. Do we get something concrete from the powers that be on Nov. 5th, or does Douglas Loe downgrade Oncy. Place your bets.

[Noteable]

The analyst's estimate of US$ 7-8 Billion acquisition price for Aurinia voclosporin represents approval in only one indication for its orally administered lupus nephritis (LN) medication known as Lupkynis. Analyst's thinks that Lupkynis could generate up to $ 1 Bln in peak sales based on an estimated 100,000 adults in the U.S. who are currently afflicted with this potentially

[Noteable]

Presently 4 analysts offering 12-month price forecasts for Oncolytics Biotech Inc (ONCY) have a median target of 6.88, with a high estimate of 15.00 and a low estimate of 4.77.  The current consensus among 4 polled investment analysts is to buy stock in Oncolytics Biotech Inc. This rating has held steady since August, when it was unchanged from a buy rating. Doug

[Noteable]

Correction:  Doug Loe of Leede Jones Gable Inc. has maintained a 12 month target on ONCY of US$ 8.50

[inthno]

Hey Jack, I was typing and posting before you had put out the correction and hit the post button so tone it down as you have a tendancy to put out a lot of corrections. I too am trying to keep people informed and keeping it real at least..

[westcoast1000]

Thanks for the info inthno. And I have also always followed Note.

[Noteable]

Well "Da-Man" da "dreamer" .. if it took youwell over  6 minutes to come up with your posted "junk" to my response then  "Jack" has plenty over you,

[Noteable]

Isotechnicka's downfall was that in 2008 the Swiss Big Pharma company Roche unexpectedly pulled out of their $215 co-development licensing deal with Isotechnika for theu use of voclosporin in transplantation. However the now eventually Swiss controlled drug voclosporin, which has been at the center of all the deal-making that effectively favored the Swiss, is also now on the main-stage of the

[inthno]

Don"t know why you have to be like that, I did not see your response at the time as stockhouse did not automatically update. And wow a whole 6 minutes. Was just trying to help. You know, you really do not have a clue, I don't aimlessly attack people just because. Been around a lot longer than you and attended many AGMS and met and talked with all of them in person. Don't think you can

[fox7mf]

Agreed. We have been hearing for a long while that ONC is in negotiations with BP. So...let's go, get a gd deal done! I remain confident & hopeful that said deal will come to fruition.

[Noteable]

Dear 'Da-Man' or "dreamer" or whoever you are now ... your sikken attitude keeps leading you to make assumptions that are not based in fact, such as your assertion that you have been in ONCY longer than I have, when you have no way of knowing how long I have owned the stock. It's these kind of absurd assumptions and those that you have shared on the Yahoo message board that

[inthno]

Well I was kinda wondering how long it would take you to post. Nice to know you have shares in the company and you are right, I will admit I do not know how long you have been in this company. My best guess is not as long as me. And I did not mistate any facts about the company. Matt did vote himself a 100k raise, and the sp does suck and we do not have any institutional support that makes any

[Noteable]

inthno, Da-Man, dreamer - If you don't know, then stop trying to post as though you do ! And why don't you post what you consider your evidence on any 100 K raise in Matt Coffey's salary since the information from ONCY's latest annual report (2020)(page 18) shows the following and either reveals that you are contiue to post to falsehoods such as you have, or that like to fabricate

[Noteable]

https://d1io3yog0oux5.cloudfront.net/_eee13055ef70b3dbbe86117a26d48987/oncolyticsbiotech/db/319/2553/management_information_circular/ONCY+Information+Circular.pdf

[Noteable]

Correction - Should read: Year - 2019 - Salary $ 525,000 - ($50 K raise from 2018)  : Total compensation $   964,677 Cdn

[inthno]

I don't know why you make me do this and I am sure you will not apologize as you are never wrong.and for some reason you did not want to include the 2021 salary. Oh and look a little farther a 750,000 physical fitness bonus....they are not hurting too badly. Boom gotcha 2 Amendment to the Employment Agreement The Employment Agreement Section 3 – Remuneration is amended as follows: (1

[inthno]

whoops I made a mistake and apoligize... It is a 750.00 fitness benefit, I added and extra 0 , my bad and I admit it

[inthno]

Also your direct quote of Matt's compensation for 2019 I was only talking about base salary but total compensation for Matt went from 964,677 to Total compensation $ Dr. Matthew C. Coffey(3) President and Chief Executive Officer 2020 540,750 — 631,970 243,000 N/A N/A 73,657 1,489,377 which is an acutal increase of 524,700 in one year , now that's a raise if I ever saw one. Year - 2019 -